Fast Facts
#3
in NIH Funding
Top Ranked
consistently ranked a top tier residency program
30+
active clinical trials
Neurosurgery News & Innovations
Comprehensive patient care
National leaders in every subspecialty offer personalized, team-based care for the full range of adult and pediatric neurosurgical conditions.
Showing: All results

Commitment to innovation
Our rare focus on innovation and technology allows us to offer patients the very latest advances and optimal treatments — many developed by our own highly skilled surgeons.

Need to make an appointment?
Offering in-person visits at nine convenient locations.
Excellence in education
Our seven-year residency and one-year fellowship prepare trainees for successful careers in academic neurosurgery.
- Mentorship from pioneers in the field
- Extraordinary research opportunities
- High-volume, comprehensive clinical practice
- Collaborative, all-encompassing culture

News
Open Faculty Position – Functional Neurosurgeon-Scientist
The Taylor Family Department of Neurosurgery at Washington University in St. Louis is seeking a motivated Functional Neurosurgeon-Scientist to join our distinguished program. The selected candidate will have the chance to continue a well-established functional practice at one of the nation’s premier academic medical centers and practice at BJC hospitals, one of the largest nonprofit […]
AI-Driven Blood Test Shows Promise for Early Brain Cancer Detection
Dr. Dimitrios Mathios, in collaboration with Johns Hopkins Kimmel Cancer Center, has developed an innovative blood test that has the potential to transform early brain cancer detection. This approach identifies DNA fragments from both tumors and immune cells in blood samples, potentially leading to earlier diagnoses. The study, published on April 29 in Cancer Discovery and […]
Dr. Thompson Awarded R01 Grant
A huge congratulations to Eric Thompson, MD, who was recently awarded an R01 grant from the National Institutes of Health (NIH)! He will use this to support his project, which focuses on cancer treatment research and aims to conduct a multi-institutional Phase I/II trial. This trial uses a novel brain tumor vaccine combined with an […]













